메뉴 건너뛰기




Volumn 47, Issue 7, 2010, Pages 830-831

Iatrogenic Cushing's syndrome due to coadministration of ritonavir and inhaled budesonide in an asthmatic human immunodeficiency virus infected patient

Author keywords

asthma; budesonide; corticosteroid; CYP3A4 inhibitor; HIV; iatrogenic Cushing's syndrome

Indexed keywords

BUDESONIDE PLUS FORMOTEROL; EMTRICITABINE; FLUTICASONE PROPIONATE PLUS SALMETEROL; FOSAMPRENAVIR PLUS RITONAVIR; HYDROCORTISONE; LOPINAVIR PLUS RITONAVIR; MONTELUKAST; TENOFOVIR; BRONCHODILATING AGENT; BUDESONIDE; CYP3A4 PROTEIN, HUMAN; CYTOCHROME P450 3A INHIBITOR; HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE INHIBITOR; RITONAVIR;

EID: 77956521594     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.3109/02770903.2010.485666     Document Type: Article
Times cited : (55)

References (13)
  • 1
    • 66149168940 scopus 로고    scopus 로고
    • Iatrogenic Cushing's syndrome in HIV-infected patients receiving ritonavir and inhaled fluticasone: Description of four new cases and review of the literature
    • Valin N, De Castro N, Garrait V, Bergeron A, Bouche C, Molina JM. Iatrogenic Cushing's syndrome in HIV-infected patients receiving ritonavir and inhaled fluticasone: description of four new cases and review of the literature. J Assoc Physicians AIDS Care 2009; 8:113-121.
    • (2009) J Assoc Physicians AIDS Care , vol.8 , pp. 113-121
    • Valin, N.1    De Castro, N.2    Garrait, V.3    Bergeron, A.4    Bouche, C.5    Molina, J.M.6
  • 2
    • 23044467452 scopus 로고    scopus 로고
    • Iatrogenic Cushing's syndrome with osteoporosis and secondary adrenal failure in human immunodeficiency virus-infected patients receiving inhaled corti-costeroids and ritonavir-boosted protease inhibitors: Six cases
    • DOI 10.1210/jc.2005-0036
    • Samaras K, Pett SL, Gowers A, McMurchie M, Cooper DA. Iatrogenic Cushing's syndrome with osteoporosis and secondary adrenal failure in human immunodeficiency virus-infected patients receiving inhaled corti-costeroids and ritonavir-boosted protease inhibitors: six cases. J Clin En-docrinol Metabolism 2005; 90(7):4394-4398. DOI 10.1210/jc.2005-0036
    • (2005) J Clin En-docrinol Metabolism , vol.90 , Issue.7 , pp. 4394-4398
    • Samaras, K.1    Pett, S.L.2    Gowers, A.3    McMurchie, M.4    Cooper, D.A.5
  • 3
    • 56749153964 scopus 로고    scopus 로고
    • Iatrogenic Cushing's syndrome after epidural triamcinolone injections in an HIV type 1-infected patient receiving therapy with ritonavir-lopinavir
    • Ramanthan R, Pau AK, Busse KH, Zemskova M, Nieman I, Kwan R, et al. Iatrogenic Cushing's syndrome after epidural triamcinolone injections in an HIV type 1-infected patient receiving therapy with ritonavir-lopinavir. Clin Infect Dis 2008; 47(12):e97-99.
    • (2008) Clin Infect Dis , vol.47 , Issue.12
    • Ramanthan, R.1    Pau, A.K.2    Busse, K.H.3    Zemskova, M.4    Nieman, I.5    Kwan, R.6
  • 4
    • 33646016085 scopus 로고    scopus 로고
    • Cushing's syndrome with secondary adrenal insufficiency from concomitant therapy with ritonavir and fluticasone
    • Johnson SR, Marion AA, Vrchoticky T, Emmanuel PJ, Lujan-Zilbermann J. Cushing's syndrome with secondary adrenal insufficiency from concomitant therapy with ritonavir and fluticasone. J Pediatr 2006; 148:386-388.
    • (2006) J Pediatr , vol.148 , pp. 386-388
    • Johnson, S.R.1    Marion, A.A.2    Vrchoticky, T.3    Emmanuel, P.J.4    Lujan-Zilbermann, J.5
  • 5
    • 33645960081 scopus 로고    scopus 로고
    • Ritonavir and fluticasone: Beware of the potentially fatal combination [editorial]
    • Li AM. Ritonavir and fluticasone: beware of the potentially fatal combination [editorial]. J Pediatr 2006; 148:294-295.
    • (2006) J Pediatr , vol.148 , pp. 294-295
    • Li, A.M.1
  • 6
    • 47649110602 scopus 로고    scopus 로고
    • Adrenal suppression and Cushing's syndrome secondary to an interaction between ritonavir and fluticasone: A review of the literature
    • Foisy MM, Yakiwchuk EMK, Chiu I, Singh AE. Adrenal suppression and Cushing's syndrome secondary to an interaction between ritonavir and fluticasone: a review of the literature. HIV Med 2008; 9:389-396.
    • (2008) HIV Med , vol.9 , pp. 389-396
    • Foisy, M.M.1    Emk, Y.2    Chiu, I.3    Singh, A.E.4
  • 8
    • 0031895196 scopus 로고    scopus 로고
    • Comparisonofinhaled corticosteroids
    • Kelly HW. Comparisonofinhaled corticosteroids. Ann Pharmacother 1998; 32:220-232.
    • (1998) Ann Pharmacother , vol.32 , pp. 220-232
    • Kelly, H.W.1
  • 9
    • 0030048729 scopus 로고    scopus 로고
    • Pharmacodynamics and pharmacokinetics of inhaled corticos-teroids
    • Johnson M. Pharmacodynamics and pharmacokinetics of inhaled corticos-teroids. J Allergy Clin Immunol 1996; 97:169-178.
    • (1996) J Allergy Clin Immunol , vol.97 , pp. 169-178
    • Johnson, M.1
  • 10
    • 27944433384 scopus 로고    scopus 로고
    • Prednisolone pharmacokinetics in the presence and absence of ritonavir after oral prednisone administration to healthy volunteers
    • Penzak SR, Formentini E, Alfaro RM, Long M, Natarajan V, Kovacs J. Prednisolone pharmacokinetics in the presence and absence of ritonavir after oral prednisone administration to healthy volunteers. J Acquir Immune Defic Syndr 2005; 40:573-580.
    • (2005) J Acquir Immune Defic Syndr , vol.40 , pp. 573-580
    • Penzak, S.R.1    Formentini, E.2    Alfaro, R.M.3    Long, M.4    Natarajan, V.5    Kovacs, J.6
  • 11
    • 50949099671 scopus 로고    scopus 로고
    • Influence of antiretroviral drugs on the pharmacokinetics of prednisolone in HIV-infected individuals
    • Busse KH, Formentini E, Alfaro RM, Kovacs JA, Penzak SR. Influence of antiretroviral drugs on the pharmacokinetics of prednisolone in HIV-infected individuals. J Acquir Immune Defic Syndr 2008; 48:561-566.
    • (2008) J Acquir Immune Defic Syndr , vol.48 , pp. 561-566
    • Busse, K.H.1    Formentini, E.2    Alfaro, R.M.3    Kovacs, J.A.4    Penzak, S.R.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.